Use of Cyclooxygenase Inhibitors and Risk of Melanoma in High‐Risk Patients
Ramirez C, Ma F, Federman D, Kirsner R. Use of Cyclooxygenase Inhibitors and Risk of Melanoma in High‐Risk Patients. Dermatologic Surgery 2006, 31: 748-753. DOI: 10.1111/j.1524-4725.2005.31703.Peer-Reviewed Original ResearchHigh-risk patientsRisk of melanomaCOX inhibitorsCyclooxygenase inhibitorOutcome measuresMiami Veterans Affairs Medical CenterVeterans Affairs Medical CenterChemoprevention of melanomaCOX inhibitor useCOX inhibitor usersNew melanoma diagnosisHigh-risk subjectsMetastasis of melanomaIndividual outcome measuresPrevious melanomaInhibitor usersInhibitor useRetrospective cohortMelanoma recurrenceNew melanomasResults EightyMelanoma incidenceMedical CenterTumor depthMelanoma metastases